Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial

World Journal of Gastroenterology

Volumn 12, Issue 9, 2006, Pages 1403-1407

  Romanelli, Roberto Giulio ^a   La Villa, Giorgio ^a   Barletta, Giuseppe ^a   Vizzutti, Francesco ^a   Lanini, Fabio ^a   Arena, Umberto ^a   Boddi, Vieri ^a   Tarquini, Roberto ^a   Pantaleo, Pietro ^a   Gentilini, Paolo ^a   Laffi, Giacomo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Ascites; Circulatory dysfunction; Cirrhosis; Diuretics; Effective plasma volume; Human albumin; Plasma expansion; Renin aldosterone axis

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FUROSEMIDE; SPIRONOLACTONE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; ASCITES; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INFUSION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK REDUCTION; SURVIVAL RATE;

EID: 33645526109     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i9.1403     Document Type: Article

References (28)

1. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, Caballeria J, Rodes J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122-128
2. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-475
3. Gentilini P, Laffi G, La Villa G, Romanelli RG, Buzzelli G, Casini-Raggi V, Melani L, Mazzanti R, Riccardi D, Pinzani M, Zignego AL. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol 1997; 92: 66-72
4. Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000; 32: 157-170
5. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003; 38 Suppl 1: S69-89
6. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157
7. Levy M. Pathogenesis of sodium retention in early cirrhosis of the liver: evidence for vascular overfilling. Semin Liver Dis 1994; 14: 4-13
8. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266
9. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646-1654
10. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-409
11. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30: 639-645
12. Gentilini P, La Villa G, Romanelli RG, Foschi M, Laffi G. Pathogenesis and treatment of ascites in hepatic cirrhosis. Cardiology 1994; 84 Suppl 2: 68-79
13. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ 2001; 165: 1339-1341
14. Runyon BA. Historical aspects of treatment of patients with cirrhosis and ascites. Semin Liver Dis 1997; 17: 163-173
15. Erstad BL, Gales BJ, Rappaport WD. The use of albumin in clinical practice. Arch Intern Med 1991; 151: 901-911
16. Losowsky MS, Atkinson M. Intravenous albumin in the treatment of diuretic-resistant ascites in portal cirrhosis. Lancet 1961; 2: 386-389
17. Wilkinson P, Sherlock S. The effect of repeated albumin infusions in patients with cirrhosis. Lancet 1962; 2: 1125-1129
18. Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841-856
19. Planas R, Gines P, Arroyo V, Llach J, Panes J, Vargas V, Salmeron JM, Gines A, Toledo C, Rimola A. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990; 99: 1736-1744
20. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13: 707-713
21. Fassio E, Terg R, Landeira G, Abecasis R, Salemne M, Podesta A, Rodriguez P, Levi D, Kravetz D. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 1992; 14: 310-316
22. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Sola R, Gines P, Terg R, Inglada L, Vaque P, Salerno F, Vargas V, Clemente G, Quer JC, Jimenez W, Arroyo V, Rodes J. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-1010
23. Gentilini P, Bernardi M, Bolondi L, Craxi A, Gasbarrini G, Ideo G, Laffi G, La Villa G, Salerno F, Ventura E, Pulazzini A, Segantini L, Romanelli RG. The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. Dig Liver Dis 2004; 36: 539-546
24. Brinch K, Moller S, Bendtsen F, Becker U, Henriksen JH. Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003; 39: 24-31
25. Jalan R, Kapoor D. Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci (Lond) 2004; 106: 467-474
26. Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, Liard JF, Martin PY, Schrier RW. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 1998; 28: 851-864
27. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, Jimenez W, Gaya J, Rivera F, Rodes J. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94: 482-487
28. Kobayashi K, Nakamura N, Sumi A, Ohmura T, Yokoyama K. The development of recombinant human serum albumin. Ther Apher 1998; 2: 257-262